INDF Financial Overview Q2 2024
INDF Financial Overview Q2 2024
Subsidiary
Update Maret 2024
Business Structure
Branded Consumer Products
Source: Annual Report ICBP 2022
Source: webiste [Link]
BOGASARI
AGRIBISNIS
Source: Annual Report 2022
INDF
in Million IDR
Q2 2024 Q1 2024
REVENUE
Gain (loss) from fair value of biological assets 91,392 0.2% 68,267
RELATED PARTIES
Transactions with Related Parties
Accounts Receivable - Trade 1,093,284 0.53% 1,454,357
Accounts Receivable - Non-trade 414,856 0.20% 423,988
Trade Payables 189,807 0.19% 205,219
Due to Related Parties 627,213 0.64% 627,213
Sales 4,984,461 8.69% 2,801,431
Purchases 310,302 0.82% 184,464
Royalty and Technical Income 40,007 4.63% 6,343
Pump service expense and other
Rental Expense
Outsourcing Expense 233,168 2.40% 122,061
Insurance Expenses 8,776 1.00% 38,496
V-SAT Expenses
Consultancy Expenses
Insurance Expenses
Details of Revenue
Related parties 4,984,461 8.7% 2,801,431
Third parties 52,311,848 91.3% 27,990,107
Total Sales 57,296,309 100.0% 30,791,538
Details of suppliers with purchases transactions that represnet more than 10% of revenue
None
TOTAL - 0.0% -
Key Management Compensation
Salaries and other short-term compensation benefits
% of Revenue 0.0% 0.0%
% of Net profit 0.0% 0.0%
ASSET
Cash and Cash Equivalent 35,736,399
Account Receivable 9,466,721
Inventory 16,858,345
Investments 9,832,107
Other Current Assets 4,683,487
Total Current Assets 76,577,059
Investment 9,621,585
Fixed Asset - neto 47,087,069
Goodwill 56,352,086
Other non-Current Assets 11,546,212
Total non-Current Assets 124,606,952
LIABILITIES
Account Payable 5,267,103
Bonds payable 44,913,702
Bank Loan 28,484,890
Other Liabilities 19,594,991
Total Liabilities 98,260,686
EQUITY
Share Capital + Additional paid-in capital 1,161,775
Retained Earnings 48,670,921
Others 53,090,629
Total Equity 102,923,325
-
Inventory
Average Inventory
Average Receivables
Average Payable
COGS
Days Inventory Outstanding (Days)
Days Sales Outstanding (Days)
Days Payable Outstanding (Days)
Cash Conversion Cycle (DAYS)
Q1 2024 FY 2023 2022
- - -
15,865,435 14,600,605
8,129,501 7,953,289
5,363,053 5,264,723
75,653,142 76,858,593
77 69
27 26
26 25
77 71
2021 2020 2019
- - -
11,917,134 10,404,569 10,651,431
7,027,586 5,917,582 5,404,002
4,782,345 4,464,719 4,275,414
66,871,514 54,979,425 53,876,594
65 69 72
26 26 26
26 30 29
65 66 69
2018
8,809,253
5,401,971
11,644,156
4,118,936
3,298,302
33,272,618
4,171,390
42,388,236
4,320,534
12,385,018
63,265,178
96,537,796
4,028,945
1,992,058
22,444,332
18,155,661
46,620,996
1,161,775
23,303,960
25,451,065
49,916,800
96,537,796
-
INDF
in Million IDR
76,785,002 73,491,800
(35,293,255) (38,135,479)
(28,147,253) (29,420,492)
13,344,494 5,935,829
(4,463,812) (7,236,247)
4,063,511 -
72,954 59,956
- (58,198)
(256,479) (3,989,193)
(583,826) (11,223,682)
(1,974,386) (3,484,931)
(5,685,849) 2,699,814
(7,660,235) 48,125
(160,160) 335,967
4,940,273 (4,903,761)
Working Capital
2020 2019
(1,023,097) (4,062)
(1,491,727) 1,985,451
54,217 4,063,444
(962,344) 760,205
(3,422,951) 6,805,038
3,289,013 (6,517,240)
(133,938) 287,798
2020 2019
8,752,066 5,902,729
3,654,729 3,226,240
(4,398,300) (4,463,812)
(133,938) 287,798
9,457,197 8,880,682
7,874,557 4,952,955
LK INDF FY 2020
Fair value of identifiable assets and liabilities of PCL and its subsidiaries at the date of acquisition:
Million IDR
Assets
Cash and cash equivalents 1,385,452
Other current assets 3,317,125
Property, plant and equipment 1,338,482
Long-term investments (DPFP) 6,596,056
Other non-current assets 58,436
total assets 12,695,551
Liabilities
Other short-term liabilities 1,709,010
Long-term liabilities 196,838
total liabilities 1,905,848
Fair value of identifiable net assets 10,789,703
Non-controlling interest in proportionate share of identifiable net assets of PCL subsidiaries (19,141,291)
Goodwill on acquisition 52,230,316
Transaction value of acquisition of 100% shares of PCL 43,878,728
Less cash and cash equivalents of acquired subsidiaries (1,385,452)
Less retention value (9,556,300) paid in Q2 2022 amounting to
Acquired subsidiaries, net of cash and overdraft acquired 32,936,976
37.6%
Acquisition offer Febuary 2020
Signing of conditional share purchase agreement May 2020
Completion of acquisition August 27, 2020
USD 650,000,000 Retention value paid on April 30, 2022 or other date after p
Total Cashflow for the acquisition of PCL by ICBP:
August 27, 2020 32,936,976
Q2 2022 9,331,551
42,268,527
4,020,486 (866,250)
NET SALES
in Million IDR
56,640,187 57.0% 64,934,753 58.6% 18,427,867 60.3% 34,084,864 60.8% 51,007,329 60.8%
21,259,559 21.4% 25,967,302 23.4% 7,156,148 23.4% 12,801,899 22.8% 18,560,266 22.1%
16,424,726 16.5% 13,696,658 12.4% 2,990,255 9.8% 5,583,233 10.0% 8,998,442 10.7%
5,021,146 5.1% 6,231,559 5.6% 1,968,433 6.4% 3,616,599 6.4% 5,322,163 6.3%
99,345,618 100.0% 110,830,272 100.0% 30,542,703 100.0% 56,086,595 100.0% 83,888,200 100.0%
49,182,414 49.5% 57,326,171 51.7% 16,322,405 53.4% 27,010,608 48.2% 40,162,649 47.9%
16,483,951 16.6% 18,133,271 16.4% 4,622,871 15.1% 9,351,745 16.7% 14,486,958 17.3%
(75,466) -0.1% 8,101 0.0% (28,303) -0.1% (10,298) 0.0% (14,258) 0.0%
1,280,615 1.3% 1,391,050 1.3% 139,825 0.5% 2,428,601 4.3% 3,069,353 3.7%
66,871,514 67.3% 76,858,593 69.3% 21,056,798 68.9% 38,780,656 69.1% 57,704,702 68.8%
MODERAT CONSERVATIVE
FIDENTIAL
0.0% - 0.0%
FIDENTIAL
#DIV/0! - #DIV/0!
-
#DIV/0!
INDF
in Million IDR
Q2 2024 Q3 2023
REVENUE
Net Sales 57,296,309 83,888,200
Cost of Goods Sold (37,490,126) -65.4% (57,704,702) -68.8%
GROSS PROFIT 19,806,183 34.6% 26,183,498 31.2%
Selling and distribution expenses (5,946,178) -10.4% (8,242,916) -9.8%
General and administrative expenses (2,840,061) -5.0% (3,812,653) -4.5%
Gain (loss) from fair value of biological assets 91,392 0.2% 20,239 0.0%
Other operating income 863,967 1.5% 695,474 0.8%
Other operating expenses (224,275) -0.4% (620,661) -0.7%
INCOME FROM OPERATIONS 11,751,028 20.5% 14,222,981 17.0%
Finance income 1,088,326 1.9% 1,123,208 1.3%
Finance expenses (5,164,608) -9.0% (2,521,821) -3.0%
Final tax on interest income (143,212) -0.2% (115,873) -0.1%
Share in net gains/(losses) of associates and joint ventures (51,297) -0.1% 111,218 0.1%
INCOME BEFORE INCOME TAX EXPENSE 7,480,237 13.1% 12,819,713 15.3%
Income tax expense (1,637,858) -2.9% (3,017,307) -3.6%
INCOME FOR THE PERIOD 5,842,379 10.2% 9,802,406 11.7%
Note:
NCI cukup signifikan, Forecast EPS tidak memperhitungkan NCI
FORECASTING Q3 2024
CONFIDENTIAL
INDF
in Million IDR STATEMENT OF FINANCIAL POSITION
ASSET
INDICATOR Cash and Cash Equivalent
Predictibility Account Receivable
- Business Inventory
- Revenue Investments
- Cashflow Other Current Assets
Durability Total Current Assets
Capability
- Market Share Investment
- Management to stakeholder Fixed Asset - neto
Goodwill
Valuation = Today Assets + Next Cashflow in Million IDR Other non-Current Assets
Total non-Current Assets
Today Assets -
Next Cashflow - TOTAL ASSETS
2024
2025 LIABILITIES
2026 Account Payable
2027 Bonds payable
2028 Bank Loan
Other Liabilities
Total - Total Liabilities
Market cap
difference between total valuation and market
cap
- EQUITY
#DIV/0! Share Capital + Additional paid-in capital
#DIV/0! Retained Earnings
Others
Total Equity
5,267,103 -
44,913,702 -
28,484,890 -
19,594,991 -
98,260,686
1,161,775
48,670,921
53,090,629
102,923,325
201,184,011 -
No. Q1 2024 Indicator
CONFIDENTIAL
Notes:
Conditions as reported in Q1 2024
CONFIDENTIAL
Note:
Condition as reported in Q1 2024
No Strength Description
CONFIDENTIAL
Note:
The main power of the company to run its business in order to survive
No Downside :
CONFIDENTIAL
Note:
Worst case scenario that could disrupt the company's business, may or may not
happen